6th Annual Conference on Psychedelics & Psychedelic Medicine
November 13-14, 2026
MGH Starr Center, Boston
Friday, November 13th
8:30 – 8:35 AM Welcome & Introduction
Franklin King, MD
Module 1: Introduction and Keynote
8:35 – 8:55 AM Psychedelic Pharmacology for Clinicians
Franklin King, MD
8:55 – 9:45 AM Keynote: Psychedelic-Assisted Therapy: Evidence, Experience, and Ongoing Questions
Stephen Ross, MD
9:45 – 10:15 AM Keynote Panel Discussion
Moderator: Franklin King, MD
Panelist: Stephen Ross, MD
10:15 – 10:30 AM Coffee Break
Module 2: Neurobiology & Brain States
10:30 – 11:00 AM Cognitive Networks and the Neuroscience of Depression Under Psychedelics
Sharmin Ghaznavi, MD, PhD
11:00 – 11:30 AM Plant Medicines and the Psychedelome
Stephen Haggarty, PhD
11:30 – 12:00 PM Advanced Meditation and the Third Wave of Meditation Research
Matthew Sacchet, PhD
12:00 – 12:30 PM Panel Discussion
Moderator: Jerrold Rosenbaum, MD
Panelists: Sharmin Ghaznavi, MD, PhD; Stephen Haggarty, PhD; Matthew Sacchet, PhD
12:30 -1:30 PM Lunch Break
Module 3: Therapeutic Models
1:30 – 2:00 PM Ketamine and Esketamine in Academic Psychiatry
Cristina Cusin, MD
2:00 – 2:30 PM Ketamine-Assisted Psychotherapy and Coaching-Informed Care
Maren Nyer, MD, PhD
2:30 – 3:00 PM Psychoanalysis and Psychotherapy in Psychedelic Treatment
Roxanne Sholevar, MD
3:00 – 3:30 PM Psychedelics in Cancer Care: Update on State of Current Research
Yvan Beaussant, MD, MSc
3:30 – 4:00 PM Panel Discussion
Moderator: Franklin King, MD
Panelists: Cristina Cusin, MD; Maren Nyer, MD, PhD; Roxanne Sholevar, MD
4:00 PM Adjourn
Saturday, November 14th
8:30 – 8:35 AM Welcome & Introduction
Franklin King, MD
Module 4: Clinical Expansion, Psychosomatics, and Translational Imaging
8:35 – 9:05 AM Implementation Challenges in Psychedelic Care
Peter Hendricks, PhD
9:05–9:35 AM Psychedelics & Borderline Personality Disorder: Too Risky, or Potential Treatment
Jenna Traynor, PhD
9:35–10:05 AM MDMA-Assisted Therapy and Simultaneous Patient-Therapist Neuroimaging in Pain
Vitaly Napadow, PhD
10:05–10:35 AM Panel Discussion
Moderator: Franklin King, MD
Panelists: Peter Hendricks, PhD; Jenna Traynor, PhD; Vitaly Napadow, PhD
10:35–10:50 AM Coffee Break
Module 5: Culture & Naturalistic Risk
10:50–11:20 AM Psychedelic Churches and Sacred Use
Jeffrey Breau, PhD
11:20–11:50 AM Population-Level Risks in Naturalistic Psychedelic Use
Grant Jones, PhD
11:50–12:20 PM Panel Discussion
Moderator: Franklin King, MD
Panelists: Jeffrey Breau, PhD; Grant Jones, PhD
12:20–1:20 PM Lunch Break
Module 6: Experience, Meaning, and Clinical Risk
1:20–1:50 PM Studying Psychedelics in Academic Medicine: Methodological and Conceptual Challenges
Franklin King, MD
1:50–2:20 PM Music in Psychedelic Therapy Sessions
Lisa Summer, PhD
2:20–2:50 PM Clinical Risks and Adverse Outcomes in Psychedelic Therapies
Kelley O’Donnell, MD, PhD
2:50–3:20 PM Panel Discussion
Moderator: Franklin King, MD
Panelists: Lisa Summer, PhD; Kelley O’Donnell, MD, PhD
3:20 – 3:30 PM Closing Remarks & Adjourn
Franklin King, MD
Franklin King, MD
Director, Training and Education, Center for Neuroscience of Psychedelics, Massachusetts General Hospital
Instructor in Psychiatry, Harvard Medical School
Yvan Beaussant, MD, MSc
Assistant Professor in Medicine
Adult Palliative Care
Department of Supportive Oncology
Dana-Farber Cancer Institute
Harvard Medical School
Jeffrey Breau, PhD, MDiv.
Program Lead for Psychedelics and Spirituality
Harvard Divinity School; Center for the Study of World Religions
Cristina Cusin, MD
Depression Clinical and Research Program
Director, Ketamine Clinic
Massachusetts General Hospital
Associate Professor in Psychiatry
Harvard Medical School
Sharmin Ghaznavi, MD, PhD
Massachusetts General Hospital
Center for the Neuroscience of Psychedelics
Associate Director and Scientific Director of Cognitive Neuroscience
Stephen J. Haggarty, PhD
Director, Chemical Neurobiology Laboratory
Co-Director, MGH Precision Therapeutics Unit
Scientific Director of Neurobiology, MGH Center
for the Neuroscience of Psychedelics
Stuart & Suzanne Steele Research Scholar
Associate Professor of Neurology, Harvard Medical School
Peter S. Hendricks, PhD
University Professor and Heersink Endowed Chair
Director of Psychedelic Research
Department of Psychiatry and Behavioral Neurobiology
School of Medicine
University of Alabama at Birmingham
Grant Jones, PhD
Franklin King, MD
Director, Training and Education, Center for Neuroscience of Psychedelics, Massachusetts General Hospital
Instructor in Psychiatry, Harvard Medical School
Vitaly Napadow, PhD
LAc, Professor, Harvard Medical School
Director, Schoen and Adams Discovery Center for Chronic Pain Recovery,
Spaulding Rehabilitation Hospital
Director, Center for Integrative Pain NeuroImaging (CiPNI), Martinos Center for Biomedical Imaging,
Mass General Hospital, Spaulding Rehabilitation Hospital
Maren Nyer, MD, PhD
Clinical Psychologist & Director of Yoga Research, Massachusetts General Hospital,
Depression Clinical and Research Program (DCRP);
Assistant Professor, Harvard Medical School
Kelley O’Donnell, MD, PhD
Clinical Associate Professor of Psychiatry, NYU Grossman School of Medicine
Director of Clinical Training, NYU Langone Center for Psychedelic Medicine
Stephen Ross, MD
Professor of Psychiatry and Child & Adolescent Psychiatry
Associate Director, NYU Langone Center for Psychedelic Medicine
Director, Psychedelic Medicine Research Training Program
Bellevue Hospital Center & NYU Langone Health
NYU Neuroscience Institute
NYU Grossman School of Medicine
Matthew D. Sacchet, PhD
Associate Professor, Department of Psychiatry, Harvard Medical School
Director, Meditation Research Program, Massachusetts General Hospital
Roxanne Sholevar, MD
Staff Psychiatrist, Dana Farber Cancer Institute
Instructor in Psychiatry, Harvard Medical School
Lisa Summer, PhD, LMHC, LCAT, MT-BC, FAMI
Professor Emeritus, Anna Maria College
Director/Primary Trainer, Institute for Music & Consciousness
DFCI Psilocybin Research | Supportive Oncology
MGH Psilocybin Research | GI Unit
Jenna Traynor, PhD
Clinician-Scientist, McLean Hospital
Instructor in Psychology, HMS
We have a dedicated staff member who is available by phone 5 days per week between 8 am and 5 pm by calling 866-644-7792 or email at mghcme@mgh.harvard.edu. All inquiries will be dealt with in a timely (within one business day) and professional manner. Requests for credits or refunds will be reviewed by the Director of the Division of Professional and Public Education, Massachusetts General Hospital. Please refer to our cancellation policy for additional information.”